AVOTRES INC.

Profile

Company Names

AVOTRES INC.

Addresses

140 EAST HANOVER AVE., STE. 140, HANOVER, NJ 07927

140 EAST HANOVER AVE., STE. 140, CEDAR KNOLLS, NJ 07927

Phone Numbers

908-591-9796

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$8,000,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-05-02 
$4,000,000.00 
$4,500,000.00 
$500,000.00 
Debt 
1
2020-12-29 
$4,000,000.00 
$8,000,000.00 
$4,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JIHONG 
 
CHEN 
DIRECTOR
AVOTRES INC.
BRUCE 
 
COOPER 
DIRECTOR
CORMEDIX INC.   |  AEON GLOBAL ABSOLUTE RETURN FUND LLC   |  AEON GLOBAL EQUITY SHAREHOLDER YIELD FUND, LLC   |  AEON GLOBAL CHOICE FUND, LLC   |  AEON U.S. SMID CAP VALUE FUND, LLC   |  AVOTRES INC.
BIAO 
 
HE 
DIRECTOR
BIOECLIPSE THERAPEUTICS, INC.   |  BLUE LAKE BIOTECHNOLOGY, INC.   |  CARDEA BIO, INC.   |  APPLAUD MEDICAL, INC.   |  AVOTRES INC.   |  AVVIO MEDICAL, INC.
JOHN 
 
HOUGHTON 
EXECUTIVE OFFICER
RAYTEC METALS CORP   |  CORMEDIX INC.   |  AVOTRES INC.
HONG 
 
JIANG 
EXECUTIVE OFFICER, DIRECTOR
AVOTRES INC.
YAN 
 
LEI 
DIRECTOR
AVOTRES INC.
ALEX 
 
LI 
DIRECTOR
AVOTRES INC.
XI 
 
QIN 
EXECUTIVE OFFICER, DIRECTOR
AVOTRES INC.
ZHONGPING 
 
SUN 
DIRECTOR
AVOTRES INC.
DAN 
 
ZHAO 
DIRECTOR
AVOTRES INC.
ZIHAO 
 
ZOU 
DIRECTOR
AVOTRES INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-05-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-05-02 
2021-02-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#